Becton, Dickinson and Company
Becton, Dickinson and Company (BDX.SW) Stock Competitors & Peer Comparison
See (BDX.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BDX.SW | CHF 245.48 | N/A | 72.6B | 45.70 | CHF 5.37 | +0.68% |
| BAX.SW | CHF 84.00 | +0.00% | 42.6B | 215.38 | CHF 0.39 | N/A |
| ALC.SW | CHF 53.66 | -6.90% | 28.4B | 37.56 | CHF 1.55 | +0.48% |
| STMN.SW | CHF 87.16 | +2.88% | 13.6B | 38.19 | CHF 2.23 | +1.17% |
| YPSN.SW | CHF 283.00 | +1.51% | 3.8B | 19.79 | CHF 14.22 | +0.78% |
| TECN.SW | CHF 129.80 | +5.19% | 1.6B | -14.29 | -CHF 8.75 | +2.40% |
| SKAN.SW | CHF 46.05 | -0.22% | 1B | 63.26 | CHF 0.72 | +0.88% |
| VBSN.SW | CHF 135.50 | +1.12% | 314.3M | 17.35 | CHF 7.61 | +2.88% |
| CLTN.SW | CHF 49.05 | +3.37% | 286.2M | 19.16 | CHF 2.50 | +4.18% |
Stock Comparison
BDX.SW vs BAX.SW Comparison May 2026
BDX.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX.SW stands at 72.6B. In comparison, BAX.SW has a market cap of 42.6B. Regarding current trading prices, BDX.SW is priced at CHF 245.48, while BAX.SW trades at CHF 84.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX.SW currently has a P/E ratio of 45.70, whereas BAX.SW's P/E ratio is 215.38. In terms of profitability, BDX.SW's ROE is +0.05%, compared to BAX.SW's ROE of -0.32%. Regarding short-term risk, Volatility data is not available for a full comparison. BDX.SW has daily volatility of N/A and BAX.SW has daily volatility of 0.00.Check BAX.SW's competition here